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Abstract: Health status questionnaires provide standardized measures of patients’ perceptions 
of the impact of disease on their daily life and well-being. Factors associated with health status 
were examined in a sample of 58 outpatients with chronic obstructive pulmonary disease (COPD) 
and co-morbid anxiety and/or depression. A cross-sectional descriptive study was conducted 
with the following measures: The St. George’s Respiratory Questionnaire (SGRQ); the Beck 
Anxiety Inventory (BAI); the Beck Depression Inventory, 2nd edition (BDI); the Pittsburgh 
Sleep Quality Index (PSQI); and spirometry. Disease severity as measured with spirometry was 
not related to health status. Perceptions of poor health as implied by the health status scores were 
positively associated with symptoms of anxiety and depression, sleep disturbances, and level of 
daily functioning. There were statistically signiﬁ  cant differences between men and women on 
COPD severity, age, and the BAI scores. The ﬁ  ndings emphasize the importance of screening 
the patients at all stages of disease severity for anxiety, depression, and sleeping problems, in 
order to provide adequate care for these problems. 
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Chronic obstructive pulmonary disease (COPD) is a highly incapacitating health 
problem, which not only affects physical functioning, but also leisure and professional 
activities as well as emotional and sexual relationships (Godoy and Godoy 2003). 
COPD and associated symptoms, such as fatigue and dyspnoea, cause restrictions on 
patients’ exercise tolerance, consequently having a major impact on their ability to carry 
out daily activities, frequently resulting in reduced quality of life (Jones 2006). 
Because the airﬂ  ow obstruction in COPD is largely irreversible, interventions 
for managing the disease are primarily aimed at improving patients’ health-related 
quality of life (Cully et al 2006). As quality of life may be difﬁ  cult to measure with 
a standardized questionnaire, illness-speciﬁ  c health status questionnaires, such as 
St. George’s Respiratory Questionnaire (SGRQ) (Jones et al 1992) and Chronic 
Respiratory Questionnaire (CRQ) (Guyatt et al 1987), provide means of quantifying 
the patients’ perceptions of the general effects of COPD on their daily life and well-
being (Jones 2001, 2006). Physiological parameters have been shown to correlate with 
health status (Ståhl et al 2005), but in some studies the associations have been weak 
(Jones 2001; McCathie et al 2002), and even patients with mild disease have reported 
substantially impaired health status (Ferrer et al 1997). The impact that COPD has on 
individuals living with the disease is likely to depend on multiple factors in addition 
to the medical burden, ranging from the patient’s life circumstances and expectations 
to coping skills and psychological well-being. 
Previous research has shown that there is a high prevalence of anxiety and 
depression among COPD patients, and psychological distress has a profound impact on 
how persons with COPD experience and manage their disease (Hynninen et al 2005). International Journal of COPD 2007:2(3) 324
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Psychological distress, as indicated by symptoms of anxiety 
and depression, has been reported to account for a signiﬁ  cant 
amount of variance in health status in patients with moderate 
and severe COPD (Hajiro et al 2000; Gudmundsson et al 
2006) as well as in hospitalized patients with acute exac-
erbations (Andenæs et al 2004). Despite the frequency of 
anxiety and depression in COPD patients, only one previous 
study has focused on health status in patients with clinically 
signiﬁ  cant levels of co-morbid depression and/or anxiety. 
Using a sample of veterans with COPD, Cully, Graham et al 
(2006) found that mental health symptoms, and in particular 
symptoms of anxiety, were the most salient factors associ-
ated with health status outcomes, above and beyond COPD 
severity, medical co-morbidity, and demographic factors. 
However, participants in this study were primarily males, 
which limits the generalizability of the results.
In addition to being symptomatic of both anxiety and 
depression, disturbed sleep is also common in COPD. Sleep 
disturbance has been found to be the third most common 
symptom associated with COPD (Kinsman et al 1983), and 
studies have revealed that low total sleep time, frequent 
arousals and awakenings, and reduced amounts of slow-
wave and rapid eye movement sleep seem to characterize the 
sleep of COPD-patients (Ballard 2005). Sleep disturbance 
in patients with severe COPD may be related to symptoms, 
such as nocturnal cough, wheezing, and dyspnoea, as a 
consequence of impaired pulmonary functions and gas 
exchange during sleep (Mohsenin 2005). Psychological 
distress may, however, contribute to sleep difﬁ  culties in all 
stages of disease severity, and both anxiety and depression 
have been shown to have a negative effect on the sleep qual-
ity in COPD (Bellia et al 2003; Kapella et al 2006). Sleep 
impairment not only worsens quality of life but may also 
aggravate symptoms of the underlying medical disorder 
(Ballard 2005). Thus, further investigation of the associa-
tions between sleep problems, psychological distress, and 
health status in COPD is needed.
The present study aimed at investigating factors associ-
ated with health status in a sample of COPD outpatients in 
all stages of disease severity, who additionally were suffer-
ing from symptoms of anxiety and/or depression. Because 
sleep problems may intensify the effects of a medical illness, 
difﬁ  culties with sleep were expected to be associated with 
health status impairment. Since psychological distress seems 
to play an important role in how patients experience their 
disease, it was also hypothesized that perceived health status 
would be more strongly related to psychological distress 
than to the severity of COPD. Furthermore, as women tend 
to have higher levels of psychological distress, females were 
expected to show more health status impairment regardless 
of their COPD severity. 
Method
The study was conducted with a subsample of 58 patients 
recruited to participate in a randomized, controlled trial of 
cognitive behavioral therapy in persons with COPD and 
co-morbid anxiety and/or depression.
Participants
Persons with a COPD diagnosis, attending an outpatient pul-
monary clinic at the Haukeland University Hospital, Bergen, 
Norway, were targeted for recruitment. In addition, partici-
pants were recruited through advertisements in a newspaper 
and brochures distributed to pulmonary specialists and primary 
care physicians. A total of 327 patients were contacted and 
screened by telephone with ﬁ  ve depression and anxiety ques-
tions from the PRIME-MD patient questionnaire (Persoons 
et al 2003). Those who responded positively to at least one 
PRIME-MD anxiety or depression item and were interested 
in study participation were recruited for further screening 
and a baseline assessment (N = 78). From the 78 baseline 
assessments, 20 patients were excluded for following reasons: 
no clinically signiﬁ  cant anxiety or depression present (Beck 
Anxiety Inventory 16; Beck Depression Inventory 14) 
(N = 13), severely depressed and/or suicidal (N = 2), active 
substance use disorders (N = 2), and other reasons (N = 3).
Measures
Anxiety
The 21-item Beck Anxiety Inventory (BAI) (Beck and Steer 
1993) was used to assess anxiety severity. The BAI has been 
validated for use with older medical patients (Wetherell and 
Arean 1997) and the scale possesses strong psychometric prop-
erties related to internal consistency, validity, and test-retest 
reliability (Beck and Steer 1993). Total scores ranging from 0 
to 7 are indicative of minimal anxiety, 8–15 of mild anxiety, 
16–25 of moderate anxiety, and 26–63 of severe anxiety. 
Depression
The Beck Depression Inventory, 2nd edition (BDI; Beck, 
Steer et al 1996), a 21-item self-report measure of depression, 
was used to assess severity of depression. The BDI possesses 
strong internal consistency, factorial and convergent validity, 
and test-retest stability (Beck et al 1996), and it has been 
validated for use with medical patients (Arnau et al 2001). 
Total scores ranging from 0 to 13 are indicative of minimal International Journal of COPD 2007:2(3) 325
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depression, 14–19 of mild depression, 20–28 of moderate 
depression, and 29–63 of severe depression.
Health status
St. George’s Respiratory Questionnaire (SGRQ) was used 
to assess perceived health status. The SGRQ was developed 
to measure the impact of respiratory disease on daily life, 
health, and well-being, and it has been shown to be reliable, 
valid, and responsive when used with COPD patients (Jones 
et al 1992). Component scores measuring symptoms (Symp-
toms), impacts on daily life (Impacts), disturbance to daily 
activities (Activity), and an overall (Total) score are normally 
calculated. Each component as well as the Total is scored 
on a scale from 0 to 100, where a score of “0” is indicating 
absence of problems and a score of “100” suggest the worst 
state possible. A change in the SGRQ score of 4 units is 
considered as clinically signiﬁ  cant (Jones et al 1992).
Sleep quality
Pittsburgh Sleep Quality Index (PSQI) (Buysse et al 1989) 
was used to assess sleep difﬁ  culties. The PSQI is a 19-item 
self-rating scale designed to measure perceived quality of 
sleep during the preceding month. Psychometric evaluation 
supports its internal consistency and construct validity when 
used with medical patients (Beck et al 2004). In addition 
to a global score, PSQI provides seven component scores, 
comprising subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efﬁ  ciency, sleep disturbances, use of 
sleeping medication, and daytime dysfunction. Global scores 
greater than 5 (total range 0–21) are considered indicative 
of sleep difﬁ  culty.
COPD severity
The Forced Expiratory Volume in 1 second (FEV1) was 
used as a measure of COPD severity, as recommended by 
the Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) guidelines (GOLD 2005). Each participant com-
pleted a spirometry, administered by trained staff at the out-
patient pulmonary clinic. GOLD criteria were used to stage 
the disease severity; FEV1  80% (predicted) corresponding 
to mild COPD, FEV1 50–79% to moderate COPD, FEV1 
30–49% to severe COPD, and FEV1  29% to very severe 
COPD, respectively.
Medical co-morbidities and hospitalizations
Medical co-morbidities and number of nights in hospital 
during the past two months were assessed from participant 
self-report. Patients were provided with a list of common 
and severe medical illness categories, and the total number 
of other illnesses in addition to COPD was used to comprise 
a numeric value expressing medical co-morbidity. This 
assessment gave a possible score range of 0–14.
Data analysis
SPSS 14.0 statistical software (SPSS Inc, Chicago, III) was 
used for all data analysis. Bivariate relationships between 
variables were expressed by the pearson’s product-moment 
correlation (r). A p-value of less than 0.05 was considered 
to be statistically signiﬁ  cant. Potential statistical differences 
between two subgroups (based upon COPD severity) of 
patients were calculated by t-test for independent samples. 
Results
Table 1 provides an overview of participant characteristics. 
Thirteen (22.4%) patients had scores on the BAI indicating 
mild anxiety, and 25 (43.1%) had scores indicating moderate 
to severe anxiety. Twenty-three (39.7%) had scores on the 
BDI indicating mild depression, and 20 (34.5%) had scores 
indicating moderate to severe depression. Fifteen (25.9%) 
were classiﬁ  ed as having moderate to severe symptoms of 
both anxiety and depression. The most common medical 
co-morbidities were heart disease (28%), hypertension 
(21%), and diabetes (12%).
Bivariate relationships
Table 2 shows the Pearson moment-product correlations 
for the primary study measures. Notably, FEV1 was not 
significantly related to SGRQ or any of the other primary 
study measures. The scores of the BAI and the BDI were 
positively correlated with the scores of SGRQ Total, 
and Activity and Impact subscales. Number of nights in 
Table 1 Participant characteristics
Characteristic
Gender  Men 58.6% (n = 34), 
  Women 41.4% (n = 24) 
Mean age (SD)  62.1 (8.6)
Mean education yrs. (SD)  12.2 (3.1)
Marital status  Married 63.8% (n = 37),
  Divorced/separated 12.1% (n = 7),
  Live-in partner 10.3% (n = 6), Never
  married 6.9% (n = 4), Widowed 5.2%
  (n = 3), Unknown 1.7% (n = 1)
Mean FEV1 % predicted (SD)  53.79 (23.96)
Smoking status   Smoker 20.7% (n = 12), Ex-smoker
  74.1% (n = 43), Non-smoker
  5.2% (n = 3)
Mean number of medical 
co-morbidities (SD)  1.7 (1.3)International Journal of COPD 2007:2(3) 326
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hospital during the past two months was significantly 
correlated with the scores of SGRQ total, and Symptoms 
and Impact subscales. The scores of the PSQI component 
Daytime Functioning showed strong correlations with 
the scores of the SGRQ Total and all three subscales, 
whereas the scores of the Sleep Disturbance component 
was positively correlated with the scores of the SGRQ 
Total and Symptoms and Impact subscales.
Health status and psychological distress 
in relation to COPD severity
The mean total score on the SGRQ was 55.3, suggesting 
perceptions of overall poor health among the study partic-
ipants. When patients with mild or moderate COPD were 
compared with those with severe or very severe COPD, 
the groups did not differ. Neither were there differences 
between the groups on scores on the BAI, the BDI and 
the PSQI, Table 3 provides mean scores on the SGRQ, 
the BAI, the BDI, and the PSQI for the total sample and 
subgroups according to FEV1.
Gender differences
Comparison of men and women showed statistically 
signiﬁ  cant differences on FEV1, age, the BAI, and medical 
co-morbidity. Women had better FEV1 values, were younger, 
exhibited more anxiety on the BAI, and had more co-morbid 
medical conditions. There were no statistically signiﬁ  cant 
gender differences on the BDI, SGRQ, and the PSQI. See 
Table 4 for an overview of mean scores of men and women 
on the primary study measures.
Discussion
In COPD patients with co-morbid anxiety and/or depression, 
disease severity as measured with spirometry (FEV1) was not 
related to health status. Impaired health status was however 
positively associated with psychological distress, as indicated 
by symptoms of anxiety and depression, frequency and length 
of hospitalizations, sleep disturbances and level of daily func-
tioning. The results of this study parallel previous ﬁ  ndings 
indicating that even patients with mild-to-moderate COPD 
may report substantially impaired health, and that mental 
health distress is more strongly related to health status than 
COPD severity or medical co-morbidity. It is also notable 
that in our sample, female patients, although younger and 
with less severe COPD than men, reported higher levels of 
psychological distress and an equal impairment of health 
status compared with the males.
There is today ample evidence of high prevalence of 
psychological distress in the COPD population, and an 
increasing number of studies are also emphasizing the role 
of mental health symptoms in impaired health status. In one 
study with COPD patients discharged after hospitalization, 
anxiety and depression affected scores on the SGRQ up to 
12 units; three times what is regarded as clinically signiﬁ  cant 
(Gudmundsson et al 2006). However, less attention has been 
paid to the impact of sleep difﬁ  culties on health status. Our 
Table 2  Pearson correlations for primary study measures
Measure  SGRQ Total  SGRQ Symptoms  SGRQ Activity  SGRQ Impact  FEV1 BAI  BDI
FEV1 –0.158  –0.031  –0.228  –0.106
BAI 0.339**  0.107  0.288*  0.357**  0.100
BDI 0.360**  0.086  0.281*  0.397**  0.117  0.584***
Age –0.011  0.121  –0.063  –0.032  –0.50  –0.341**  –0.358**
Hospitalizations 0.408**  0.297*  0.241  0.419**  –0.227  0.206  –0.025
Medical Co-morbidities  0.100  –0.108  0.142  0.127  0.128  0.253  0.165
PSQI Sleep quality  0.093  0.179  –0.127  0.161  0.208  0.118  0.132
PSQI Sleep latency  –0.063  –0.014  –0.274*  0.064  0.178  –0.032  0.092
PSQI Sleep duration  0.058  –0.014  0.063  0.063  0.051  –0.080  –0.009
PSQI Sleep efﬁ  ciency  –0.055  –0.111  –0.047  –0.017  0.167  –0.027  –0.084
PSQI Sleep disturbances  0.404**  0.378**  0.189  0.409**  0.208  0.228  0.245
PSQI sleep medication  0.119  0.161  0.053  0.099  0.160  0.174  0.104
PSQI Daytime functioning  0.570***  0.374**  0.364**  0.576***  –0.043  0.251  0.197
PSQI Total  0.154  0.136  –0.017  0.211  0.231  0.116  0.102
SGRQ: St. George’s Respiratory Questionnaire; FEV1: Forced expiratory volume in 1 second; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory, 2nd edition; 
Hospitalizations: Number of nights in hospital during the last two months; Co-morbidities: Number of other medical co-morbidities; PSQI: Pittsburgh Sleep Quality Index. 
On the SGRQ, BAI, BDI and PSQI, higher scores mean greater impairment. 
*p  0.05, **p  0.01, ***p  0.001International Journal of COPD 2007:2(3) 327
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ﬁ  ndings indicate that, in addition to psychological distress, 
also sleep disturbances may be related to health status even 
in the early stages of the disease. 
Fatigue is recognized as one of the most common and 
important symptoms in COPD (Janson-Bjerklie et al 1986). 
In our sample, the PSQI component that assesses sleepi-
ness and fatigue during the day (Daytime Functioning) was 
strongly correlated with health status. A sensation of fatigue 
can be a consequence of poor sleep quality or mood disor-
ders, but there is also strong evidence for an association 
between dyspnea and fatigue, and it has been suggested that 
fatigue may be a sign of a worsening condition in people 
with COPD (Kapella et al 2006). The relationship between 
daytime functioning and health status could thus reﬂ  ect the 
impact of disease severity on patients’ perceptions of their 
health. However, relatively little is known about the speciﬁ  c 
mechanisms and triggers of fatigue, and more research is 
needed to clarify the interrelationships between fatigue and 
other factors.
Certain limitations of the present study should be noted. 
Our sample size was relatively small, which reduces the 
statistical power, decreasing the likelihood of detecting 
a signiﬁ  cant difference when one truly exists. Due to the 
fact that the current study uses a cross-sectional design, 
assumptions concerning causal relations cannot be made. 
No signiﬁ  cant relationship between COPD severity and 
health status was found in the current investigation, but this 
ﬁ  nding may be due to the deﬁ  cits related to using FEV1 as a 
measure of COPD severity. Although COPD has its primary 
effect in the lungs, changes take place also in other organs, 
and important effects of COPD, such as fatigue, may have 
no direct relationship to expiratory airﬂ  ow limitation (Jones 
2001). Thus, it is possible that the categorizations according 
to FEV1 did not accurately reﬂ  ect the severity of the disease. 
In addition, a criterion for inclusion in the current study was 
the presence of anxiety and/or depression. The relationships 
between psychological distress and health status might be 
different in other COPD populations.
Despite these limitations, the study raises some important 
issues concerning psychological disturbance and sleep prob-
lems in COPD patients, and their impact on the patients’ 
health status. Even though complaints of poor sleep are 
common and studies have established irregularities in sleep 
among COPD patients, the interrelations between sleep, 
psychological distress and health status have received 
relatively little attention. Both psychological distress and 
sleep problems may aggravate the symptoms and intensify 
the effects of COPD on health status in all stages of disease 
severity, leading to ﬁ  ndings of more impairment in health 
status as well as reduced quality of life. Or, poor health status 
Table 3 Mean scores on primary study measures, total sample and subgroups according to forced expiratory volume in one second 
(FEV1) % predicted, GOLD criteria
   FEV1 % predicted – GOLD criteria   
Scale  Total sample   Mild/moderate COPD   Severe/very severe COPD  t-test, p-values
  n = 58  FEV1  50%  FEV1  50%
    n = 29  n = 29 
SGRQ Total  55.3 (13.8)  52.9 (12.9)  57.7 (14.5)  p = 0.187
SGRQ Symptoms  61.0 (19.9)  60.7 (18.6)  61.4 (21.5)  p = 0.899
SGRQ Activity  68.0 (17.2)  64.1 (17.8)  71.9 (16.0)  p = 0.083
SGRQ Impact  46.7 (15.2)  44.5 (13.0)  48.8 (17.1)  p = 0.289
BAI  15.6 (9.7)  16.7 (9.3)  14.5 (10.2)  p = 0.408
BDI   17.6 (8.4)  18.4 (9.0)  16.8 (7.7)  p = 0.474
PSQI   8.5 (3.7)  9.3 (3.8)  7.8 (3.5)  p = 0.156
Data are presented as mean + SD. SGRQ: St. George’s Respiratory Questionnaire; BAI: Beck Anxiety Inventory; BDI: Beck Depression 
Inventory, 2nd edition; PSQI: Pittsburgh Sleep Quality Index. On the SGRQ, BAI, BDI and PSQI, higher scores mean greater impairment. 
Table 4 Mean scores on primary study measures, men and 
women
  Men n = 34  Women n = 24  t-test, p-values
FEV1  48.6 (22.8)  61.2 (24.1)  p = 0.047
Age  64.2 (7.2)  59.2 (9.7)  p = 0.029
BAI  12.9 (9.1)  19.4 (9.6)  p = 0.012
BDI  16.5 (6.8)  19.3 (9.6)  p = 0.215
Hospitalizations  1.1 (3.0)  0.5 (1.4)  p = 0.404
Medical
co-morbidities  1.4 (1.1)  2.3 (1.4)  p = 0.008
SGRQ total  54.9 (14.2)  56.0 (13.5)  p = 0.755
PSQI total  8.1 (3.6)  9.2 (3.8)  p = 0.317
Data are presented as mean + SD. FEV1: Forced expiratory volume in 1 sec-
ond; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory, 2nd edition; 
Hospitalizations: Number of nights in hospital during the last two months; Medi-
cal co-morbidities: Number of other co-morbid medical conditions; SGRQ: St. 
George’s Respiratory Questionnaire; PSQI: Pittsburgh Sleep Quality Index. On the 
SGRQ, BAI, BDI and PSQI, higher scores mean greater impairment.International Journal of COPD 2007:2(3) 328
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as a consequence of the multiple structural and functional 
effects of COPD, not captured solely by the expiratory air-
ﬂ  ow limitation, may cause psychological distress and sleep 
disturbance. In our sample, in which all patients’ had at least 
subclinical levels of anxiety or depression, sleep difﬁ  culties 
were not signiﬁ  cantly related to symptoms of psychological 
distress. However, in other studies that did not speciﬁ  cally 
target patients with anxiety or depression, psychological 
distress was found to contribute to poor sleep (Bellia et al 
2003; Kapella et al 2006).
Our ﬁ  ndings also emphasize the importance of routinely 
screening the patients for anxiety, depression, and sleeping 
problems in order to provide adequate treatment for these 
problems. A study by Roundy et al (2005) suggests that 
depressive and anxiety disorders are recognized only in 
half of the patients, and even fewer are receiving adequate 
care. Although treatment studies of anxiety and depression 
in COPD patients are few and suffer from methodological 
limitations, both pharmacologic and non-pharmacologic 
interventions have shown promising results (Brenes 2003). 
In addition, it might be useful to target sleep problems in 
interventions aimed at improving the patients’ health status 
and quality of life, and include measures of sleep quality 
when evaluating treatment outcomes.
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